NMS·$666M

SGP SpyGlass Pharma, Inc.

42SPECULATIVE

CATEGORY BREAKDOWN

GROWTH0
QUALITY0
STABILITY99
VALUATION50
GOVERNANCE47

METRIC BREAKDOWN

Revenue Growth (YoY)

Year-over-year revenue growth rate

N/A
0

> 50% strong

Gross Margin

Revenue retained after direct costs

N/A
0

> 50% strong

Cash Runway

Months of cash at current burn rate

35 months
99

> 24 months ideal

Debt / Equity

Total debt relative to shareholder equity

-1.6%
100

< 25% strong

Price / Sales

Market cap relative to trailing revenue

N/A
50

< 3x strong

Rule of 40

Growth rate plus operating margin

N/A
0

> 40 excellent

Insider Ownership

Percentage of shares held by insiders

4.3%
34

> 20% strong

Share Dilution (12M)

Share count increase over last 12 months

+4.8%
71

< 5% ideal

SCORE HISTORY

COMPARE SGP WITH…

SGPvs

SCORE ALERT

Get notified when SGP's score changes by 5+ points.

DATA INFO

Last updated: Jul 1, 2026

Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.